Mizuho’s Jared Holz joins the ‘Fast Money’ team to discuss the potential impact of expiring patents within the biotech and pharmaceuticals industries.
Trending
- Tesla sell-off on Musk-Trump feud is overdone, says Fundstrat’s Tom Lee
- Swiss government proposes tough new capital rules in major blow to UBS
- Musk vs Trump dominated, yet Germany’s Merz walked away with a win
- UK’s FCA to lift ban on crypto ETNs — here’s what it means
- TSLA, CRCL, AVGO, LULU and more
- Here’s what Wall Street has to say about Broadcom’s second-quarter results
- Jobs report May 2025:
- Trump ‘not interested’ in Musk call, White House official says
Mizuho’s Jared Holz details potential biotech, pharma acquisitions
